DE20005402U1 - External treatment for skin redness and psoriasis - Google Patents
External treatment for skin redness and psoriasisInfo
- Publication number
- DE20005402U1 DE20005402U1 DE20005402U DE20005402U DE20005402U1 DE 20005402 U1 DE20005402 U1 DE 20005402U1 DE 20005402 U DE20005402 U DE 20005402U DE 20005402 U DE20005402 U DE 20005402U DE 20005402 U1 DE20005402 U1 DE 20005402U1
- Authority
- DE
- Germany
- Prior art keywords
- psoriasis
- skin redness
- cream
- external treatment
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
sch &iacgr;&ogr; G 2sch &iacgr;&ogr; G 2
- &igr; - Keil&Schaafhausen- &igr; - Keil&Schaafhausen
PATENTANWÄLTEPATENT ATTORNEYS
Gegenstand der Erfindung ist ein Mittel zur Behandlung von Hautrötungen und Schuppenflechten auf pflanzlicher Basis.The invention relates to a plant-based agent for the treatment of skin redness and psoriasis.
Die Schuppenflechte (Psoriasis) ist eine weit verbreitete Hautkrankheit. Ihre genaue Ursache ist nicht bekannt. Die Psoriasis wird polygen vererbt und tritt bei etwa 2 % der Bevölkerung in Erscheinung. Eine Vielzahl von Behandlungsmethoden stehen bereits zur Verfügung. So wirkt z. B. ein Teerbad mit anschließender UV-Bestrahlung antipsoriatisch. Auch eine Therapie nur mit lokalen Steroiden ist wirksam, führt aber aufgrund der langen Anwendung zu starken Nebenwirkungen und sollte deshalb zu Gunsten anderer Therapien 0 aufgegeben werden.Psoriasis is a widespread skin disease. Its exact cause is unknown. Psoriasis is inherited polygenically and occurs in about 2% of the population. A variety of treatment methods are already available. For example, a tar bath followed by UV radiation has an antipsoriatic effect. Therapy with local steroids alone is also effective, but leads to severe side effects due to the long-term use and should therefore be abandoned in favor of other therapies.
Es besteht deshalb weiterhin ein erheblicher Bedarf an einem gegen Psoriasis und die damit verbundenen Hautrötungen wirksamen Mittel, das frei von unerwünschten Nebenwirkungen 5 ist. Überraschenderweise hat sich gezeigt, dass ein gegen Psoriasis wirksames Heilmittel aus einem pflanzlichen Material gewonnen werden kann.There is therefore still a significant need for a remedy that is effective against psoriasis and the associated skin redness and that is free from undesirable side effects 5. Surprisingly, it has been shown that a remedy effective against psoriasis can be obtained from a plant material.
Gegenstand der Erfindung ist deshalb ein Mittel zur äußerlichen Behandlung von Hautrötungen und Schuppenflechten, das als Wirkstoff einen Extrakt aus Walnußkernen enthält. Es kann in Form einer Creme oder Salbe zur Verfügung gestellt werden.The invention therefore relates to a product for the external treatment of skin redness and psoriasis, which contains an extract from walnut kernels as an active ingredient. It can be made available in the form of a cream or ointment.
Diese besteht vorzugsweise aus einem Basiscreme, der einenThis preferably consists of a base cream that has a
Extrakt aus Walnußkernen enthält.
35Contains extract from walnut kernels.
35
Sch 10 G 2 *.'".·.:·Sch 10 G 2 *.'".·.:·
- 2 - KEIL&SCHAAFHAUSEN- 2 - KEIL&SCHAAFHAUSEN
patentanwältepatent attorneys
Bisher sind nur die Blätter des Walnußbaumes arzneilich verwendet worden. Sie enthalten etwa 10 % Gerbstoffe, vor allem Juglon. Aufgrund des Gerbstoffgehaltes können Walnußblätter extern in Form von Bädern, Spülungen und Umschlägen bei Hautleiden wie Akne, Exzemen und Geschwüren angewendet werden. Innerlich werden Walnußblätter gelegentlich als Mittel gegen Durchfallerkrankungen eingesetzt. Eine arzneiliche Verwendung von Extrakten aus dem essbaren Teil der Walnuß, ihren Keimblättern, ist bisher nicht bekannt geworden.To date, only the leaves of the walnut tree have been used medicinally. They contain around 10% tannins, mainly juglone. Due to the tannin content, walnut leaves can be used externally in the form of baths, rinses and compresses for skin conditions such as acne, eczema and ulcers. Internally, walnut leaves are occasionally used as a remedy for diarrhea. There is no known medicinal use of extracts from the edible part of the walnut, its cotyledons.
Um so überraschender ist, dass ein Extrakt aus den stark ölhaltigen Walnußkeimblättern bemerkenswerte Wirksamkeit gegen die Schuppenflechte und die damit verbundenen Hautrötungen aufweist.It is all the more surprising that an extract from the highly oily walnut cotyledons has remarkable effectiveness against psoriasis and the associated skin redness.
Die erfindungsgemäße äußerliche Anwendung eines Extraktes aus Walnußkernen erfolgt vorzugsweise in Form einer Creme oder einer Salbe. Besonders bewährt hat sich die Herstellung einer Creme auf der Grundlage von Basiscremen, die selbst hergestellt oder auf dem Markt bezogen werden können, wie die Basiscreme 3013 der Firma Caesar & Lorentz GmbH, Hilden. Ein derartiger Basiscreme besteht aus Propylenglykol, weißer Vasiline, Sorbitol, einem Emulgator und Wasser.The external application of an extract from walnut kernels according to the invention is preferably carried out in the form of a cream or an ointment. The production of a cream based on base creams that can be made yourself or purchased on the market, such as the base cream 3013 from Caesar & Lorentz GmbH, Hilden, has proven particularly successful. Such a base cream consists of propylene glycol, white vaseline, sorbitol, an emulsifier and water.
Zur Herstellung der erfindungsgemäßen Creme werden Walnußkerne fein gemahlen. Dabei ist zu beachten, dass kein Öl austritt. Die gemahlenen Nüsse werden zusammen mit dem Basiscreme in ein Gefäß gegeben und auf 820C erwärmt. Bei dieser Temperatur sollte die Mischung 2 0 bis 3 0 Minuten gehalten werden. Die flüssige Masse wird während dieser Zeit mit einem Rührwerk (45 0 RPM) umgerührt. Anschließend werden die geschnittenen Nußkerne mit Hilfe eines Siebes, das zum Beispiel eine Maschenweite von 0,2 mm aufweisen kann, abgeseit. Die noch flüssige Creme wird dann sofort mit Hilfe einer Vakuumpumpe in Tuben oder Salbenkruken luftfrei abgefüllt. Diese BehälterTo produce the cream according to the invention, walnut kernels are finely ground. Care must be taken to ensure that no oil escapes. The ground nuts are placed in a container together with the base cream and heated to 82 0 C. The mixture should be kept at this temperature for 2 0 to 3 0 minutes. During this time, the liquid mass is stirred with a stirrer (45 0 RPM). The cut walnut kernels are then strained using a sieve, which can have a mesh size of 0.2 mm, for example. The still liquid cream is then immediately filled into tubes or ointment jars without any air using a vacuum pump. These containers
16.03.0016.03.00
sch &iacgr;&ogr; G 2 .· ,· · i .* : :: :sch &iacgr;&ogr; G 2 .· ,· · i .* : :: :
- 3 - KEIL&SCHAAFHAUSEN- 3 - KEIL&SCHAAFHAUSEN
PATENTANWÄLTEPATENT ATTORNEYS
sollten bis zum Rand gefüllt werden. Die Creme ist dann sofort mit einer Folie abzudecken und die Behälter zu verschließen, um oxidative Einwirkungen durch Luft oder Sauerstoff zu vermeiden. Im abgekühlten Zustand ist die Creme dann gebrauchsfertig. should be filled to the brim. The cream should then be immediately covered with foil and the containers closed to avoid oxidative effects from air or oxygen. Once cooled, the cream is ready for use.
Zur Behandlung der mit Schuppenflechten oder Hautrötungen befallenen Hautpartien empfiehlt es sich, das erfindungsgemäße Mittel mehrmals täglich aufzutragen und einwirken zu lassen. Schon nach einer Behandlungsdauer von 2 bis 3 Wochen zeigt sich in der Regel eine erhebliche Verbesserung der Hauterkrankung, die zur vollständigen Beseitigung der Schuppenflechte und der Hautrötungen führt, wenn die Behandlung über 6 bis 8 Wochen fortgesetzt wird.To treat the skin areas affected by psoriasis or skin redness, it is recommended to apply the agent according to the invention several times a day and allow it to take effect. After just 2 to 3 weeks of treatment, there is usually a significant improvement in the skin condition, which leads to the complete elimination of psoriasis and skin redness if the treatment is continued for 6 to 8 weeks.
16.03.00 · ··16.03.00 · ··
Claims (3)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20005402U DE20005402U1 (en) | 2000-03-22 | 2000-03-22 | External treatment for skin redness and psoriasis |
| DE20012104U DE20012104U1 (en) | 2000-03-22 | 2000-07-12 | External treatment for pain, reddening of the skin, psoriasis and neurodermatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20005402U DE20005402U1 (en) | 2000-03-22 | 2000-03-22 | External treatment for skin redness and psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE20005402U1 true DE20005402U1 (en) | 2000-07-20 |
Family
ID=7939229
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE20005402U Expired - Lifetime DE20005402U1 (en) | 2000-03-22 | 2000-03-22 | External treatment for skin redness and psoriasis |
| DE20012104U Expired - Lifetime DE20012104U1 (en) | 2000-03-22 | 2000-07-12 | External treatment for pain, reddening of the skin, psoriasis and neurodermatitis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE20012104U Expired - Lifetime DE20012104U1 (en) | 2000-03-22 | 2000-07-12 | External treatment for pain, reddening of the skin, psoriasis and neurodermatitis |
Country Status (1)
| Country | Link |
|---|---|
| DE (2) | DE20005402U1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003009860A1 (en) * | 2001-07-07 | 2003-02-06 | Lore Klett-Loch Gdbr | Preparation used for the topical treatment of pains and skin diseases |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626529A (en) | 1981-10-23 | 1986-12-02 | L'oreal | Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin |
| DE4021082A1 (en) | 1990-07-03 | 1992-01-23 | Hans Dr Lautenschlaeger | Skin care product with high lipid content - contains a bi:layer source, salts of organic acids, alcohol, stabiliser and lipid(s) |
| DE19654468C1 (en) | 1996-12-27 | 1998-01-22 | Lohmann Therapie Syst Lts | Flexible dermal or transdermal plaster for drug or cosmetic release |
| DE19831798A1 (en) | 1998-07-15 | 2000-01-27 | Mandorlo Investment Gmbh Luxem | Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement |
-
2000
- 2000-03-22 DE DE20005402U patent/DE20005402U1/en not_active Expired - Lifetime
- 2000-07-12 DE DE20012104U patent/DE20012104U1/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626529A (en) | 1981-10-23 | 1986-12-02 | L'oreal | Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin |
| DE4021082A1 (en) | 1990-07-03 | 1992-01-23 | Hans Dr Lautenschlaeger | Skin care product with high lipid content - contains a bi:layer source, salts of organic acids, alcohol, stabiliser and lipid(s) |
| DE19654468C1 (en) | 1996-12-27 | 1998-01-22 | Lohmann Therapie Syst Lts | Flexible dermal or transdermal plaster for drug or cosmetic release |
| DE19831798A1 (en) | 1998-07-15 | 2000-01-27 | Mandorlo Investment Gmbh Luxem | Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003009860A1 (en) * | 2001-07-07 | 2003-02-06 | Lore Klett-Loch Gdbr | Preparation used for the topical treatment of pains and skin diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| DE20012104U1 (en) | 2001-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT406731B (en) | SUBSTANCE MIXTURE FOR TOPICAL APPLICATION | |
| DD277210A5 (en) | THERAPEUTIC COMPOSITIONS AGAINST PSORIASIS | |
| EP0345571A1 (en) | Plant extract composition for cosmetical use | |
| CH666618A5 (en) | Skin regenerating cosmetic compsns. | |
| EP0668768B1 (en) | Composition for controlling dermatomycoses and their agents, as well as transpiration and bodily odours | |
| DE20005402U1 (en) | External treatment for skin redness and psoriasis | |
| EP0355149B1 (en) | Herbal tea composition and process for producing it | |
| CH682631A5 (en) | Herbal compsns. for promoting hair growth - contain nettle, pansy and chickweed | |
| DE68906205T2 (en) | COSMETIC AND PARAMEDICAL PREPARATIONS. | |
| EP0384308B1 (en) | Extract medicament | |
| DE3519736C2 (en) | Agents for the treatment of rheumatism and polyarthritis | |
| DE202014005062U1 (en) | elixir | |
| CH492593A (en) | Skin care products | |
| EP1455806B1 (en) | Active agent mixture containing a plant extract of convolvulaceae for treating hair problems, skin disorders and skin diseases | |
| DE3915535A1 (en) | Compsns. for treating skin disorders - contain trigonellin or trigonellic acid | |
| DE4237551C1 (en) | Use of a plant-based composition to combat dermatomycoses | |
| AT381449B (en) | METHOD FOR PRODUCING A HAIR GROWING AGENT | |
| DE19910697C2 (en) | Process for the preparation of a therapeutically active substance and use thereof | |
| DE19916935A1 (en) | Cosmetic or dermatological composition useful for treating the skin and/or hair of humans or animals comprises honey, olive oil and lemon juice | |
| DE3901575C2 (en) | ||
| EP2842543B1 (en) | Composition with cooling effect for topical application | |
| DE3930849A1 (en) | Pharmaceutical prepn. obtd. from specific citrus species - used to treat gastrointestinal disorders, esp. diarrhoea | |
| EP1530971A1 (en) | Composition for the treatment of tooth and gum diseases | |
| DE4212057C2 (en) | Preparation consisting of a solution of oleander leaves in petroleum | |
| DE102007040025A1 (en) | Hair restorer, useful e.g. for external application on skin and as shampoo, conditioner, hair tonic and lotion, comprises component of aqueous extract of bulbous plant (Alliaceae) and/or bulbous plant oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification |
Effective date: 20000824 |
|
| R163 | Identified publications notified |
Effective date: 20001219 |
|
| R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20030411 |
|
| R157 | Lapse of ip right after 6 years |
Effective date: 20061003 |